Arcadia Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $216 | Hold |
3
| – | – | ﹤0.01% | 332 |
|
|
2025
Q4 | $239 | Buy |
+3
| New | +$237 | ﹤0.01% | 341 |
|
|
2023
Q2 | – | Sell |
-11,000
| Closed | -$817K | – | 346 |
|
|
2023
Q1 | $817K | Hold |
11,000
| – | – | 0.18% | 72 |
|
|
2022
Q4 | $1.03M | Hold |
11,000
| – | – | 0.24% | 69 |
|
|
2022
Q3 | $1.05M | Hold |
11,000
| – | – | 0.25% | 69 |
|
|
2022
Q2 | $1.02M | Hold |
11,000
| – | – | 0.23% | 74 |
|
|
2022
Q1 | $1.11M | Hold |
11,000
| – | – | 0.21% | 74 |
|
|
2021
Q4 | $1.14M | Hold |
11,000
| – | – | 0.19% | 80 |
|
|
2021
Q3 | $933K | Hold |
11,000
| – | – | 0.17% | 87 |
|
|
2021
Q2 | $918K | Hold |
11,000
| – | – | 0.17% | 86 |
|
|
2021
Q1 | $828K | Hold |
11,000
| – | – | 0.17% | 86 |
|
|
2020
Q4 | $751K | Hold |
11,000
| – | – | 0.16% | 81 |
|
|
2020
Q3 | $642K | Buy |
+11,000
| New | +$684K | 0.14% | 85 |
|
|
2020
Q2 | – | Sell |
-65
| Closed | -$4K | – | 274 |
|
|
2020
Q1 | $4K | Hold |
65
| – | – | ﹤0.01% | 284 |
|
|
2019
Q4 | $5K | Hold |
65
| – | – | ﹤0.01% | 273 |
|
|
2019
Q3 | $4K | Sell |
65
-75
| -54% | -$4.44K | ﹤0.01% | 284 |
|
|
2019
Q2 | $8K | Sell |
140
-726
| -84% | -$39.1K | ﹤0.01% | 298 |
|
|
2019
Q1 | $47K | Hold |
866
| – | – | 0.01% | 198 |
|
|
2018
Q4 | $57K | Hold |
866
| – | – | 0.02% | 173 |
|
|
2018
Q3 | $68K | Hold |
866
| – | – | 0.02% | 198 |
|
|
2018
Q2 | $56K | Hold |
866
| – | – | 0.02% | 215 |
|
|
2018
Q1 | $54K | Sell |
866
-325
| -27% | -$23.3K | 0.02% | 217 |
|
|
2017
Q4 | $86K | Sell |
1,191
-142
| -11% | -$10.3K | 0.02% | 175 |
|
|
2017
Q3 | $108K | Buy |
1,333
+726
| +120% | +$57.4K | 0.03% | 154 |
|
|
2017
Q2 | $49K | Hold |
607
| – | – | 0.02% | 218 |
|
|
2017
Q1 | $48K | Hold |
607
| – | – | 0.02% | 218 |
|
|
2016
Q4 | $48K | Sell |
607
-1,093
| -64% | -$88.4K | 0.02% | 210 |
|
|
2016
Q3 | $151K | Buy |
1,700
+95
| +6% | +$8.97K | 0.05% | 126 |
|
|
2016
Q2 | $154K | Buy |
1,605
+750
| +88% | +$74.7K | 0.05% | 125 |
|
|
2016
Q1 | $89K | Hold |
855
| – | – | 0.03% | 142 |
|
|
2015
Q4 | $84K | Buy |
855
+550
| +180% | +$53.9K | 0.03% | 143 |
|
|
2015
Q3 | $29K | Buy |
305
+150
| +97% | +$15.8K | 0.01% | 161 |
|
|
2015
Q2 | $16K | Buy |
+155
| New | +$15.8K | ﹤0.01% | 199 |
|
Other funds holding CVS
Arcadia Investment Management's CVS Position: Q1 2026 in Review
Arcadia Investment Management held its CVS Health (CVS) position steady in Q1 2026 at 3 shares worth $216. The position accounts for ﹤0.01% of the portfolio, ranked #332.
Arcadia Investment Management first reported a position in CVS in Q2 2015 and has held it in 33 quarters since. The position peaked at $1.14M in Q4 2021. 1,877 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Arcadia Investment Management held 3 shares of CVS Health worth $216 as of Q1 2026.
- Arcadia Investment Management left its CVS Health share count unchanged in Q1 2026.
- CVS Health made up ﹤0.01% of Arcadia Investment Management's portfolio in Q1 2026, its #332 holding.
- Arcadia Investment Management first reported a position in CVS Health in Q2 2015 and has held it in 33 quarters since.
- Arcadia Investment Management's CVS Health position peaked at $1.14M in Q4 2021.
- 1,877 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.